99873-50-4

Basic information

• Product Name: 2,3-dibromo-3-(3',4'-dimethoxy)-phenyl ethyl propanoate
• Synonyms: 2,3-dibromo-3-(3',4'-dimethoxy)-phenyl ethyl propanoate
• CAS NO: 99873-50-4
• Molecular Weight: 396.076
• Mol File: 99873-50-4.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 2,3-dibromo-3-(3',4'-dimethoxy)-phenyl ethyl propanoate(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3-dibromo-3-(3',4'-dimethoxy)-phenyl ethyl propanoate(99873-50-4)
• EPA Substance Registry System: 2,3-dibromo-3-(3',4'-dimethoxy)-phenyl ethyl propanoate(99873-50-4)

Safety Data

• Hazardous Substances Data: 99873-50-4(Hazardous Substances Data)

Upstream product

• 20583-78-2 3,4-dimethoxy-cinnamic acid ethyl ester 
• 20583-78-2 ethyl (E)-3,4-dimethoxycinnamate 
• 14737-89-4 3,4-dimethoxy-trans-cinnamic acid 
• 120-14-9 3,4-dimethoxy-benzaldehyde 
• 2316-26-9 3,4-dimethoxycinnamic acid 

Downstream Products

• 22511-06-4 3,4-dimethoxyphenylpropiolic acid 
• 20583-78-2 3,4-dimethoxy-cinnamic acid ethyl ester 
• 816462-34-7 3,4-dimethoxyphenylpropioloyl chloride 
• 4302-52-7 4-ethynylveratrole 
• 23982-43-6 4-(3',4'-dimethoxyphenyl)-7-hydroxycoumarin 
• 185033-52-7 7,8-dihydroxy-4-(3',4'-dimethoxyphenyl)-2H-1-chromen-2-one 
• 144223-81-4 5,7-dihydroxy-4-(3,4-dihydroxyphenyl)-chromen-2-one 

Relevant articles and documents

Synthesis and biological evaluation of 4-arylcoumarins as potential anti-Alzheimer's disease agents

Alzheimer's disease (AD) is a progressive neurological degenerative disease that has complex pathogenesis. A variety of studies in humans indicate that several enzymes inhibitors can be useful in the treatment of AD, including acetylcholinesterase (AchE), butyrylcholinesterase (BuChE) and monoamine oxidase (MAO). Various substituted 4-arylcoumarin derivatives were synthesised, and their activity in vitro were investigated, including AChE/BuChE inhibitory activity, MAO inhibitory activity, and antioxidant activity. Most of the compounds were found to exhibit high inhibitory activity, and individual compounds have extremely excellent activities. Therefore 4-arylcoumarins provides an idea for drugs design for the development of therapeutic or preventive agents for AD.

An efficient bromination of alkenes using cerium(IV) ammonium nitrate (CAN) and potassium bromide

Bromination of alkenes using a combination of potassium bromide and cerium(iv) ammonium nitrate (CAN) in a two phase system consisting of water and dichloromethane affords the corresponding dibromides in excellent yield. The reaction most likely involves the addition of the bromine radical generated from bromide ion by CAN and subsequent formation of the dibromide.

Enolethers and their use as a fungicide

Enolethers and thioenolethers of formula I STR1 are disclosed. The compounds are useful for combatting phytopathogenic fungi.